Schering-Plough
SGP
#544
Rank
NZ$77.60 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Schering-Plough (SGP) - Cash on Hand

Cash on Hand as of December 2008 : NZ$5.66 Billion

According to Schering-Plough's latest financial reports the company has NZ$5.66 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Schering-Plough - Cash on Hand chart (from 1996 to 2008)

Cash on Hand by year

Year Cash on Hand Change
2008-12-31NZ$5.81 B
2006-12-31NZ$3.78 B-45.74%
2005-12-31NZ$6.97 B-0.15%
2004-12-31NZ$6.98 B7.64%
2003-12-31NZ$6.48 B282.42%
2002-12-31NZ$1.69 B-40.64%
2001-12-31NZ$2.85 B77.91%
2000-12-31NZ$1.60 B
1998-12-31NZ$1.52 B29.75%
1997-12-31NZ$1.17 B114.13%
1996-12-31NZ$0.55 B